<DOC>
	<DOCNO>NCT01758406</DOCNO>
	<brief_summary>This study prospective , randomize , double blind , control trial ass efficacy intracoronary transplantation autologous cardiac stem cell 50 patient ischemic heart failure .</brief_summary>
	<brief_title>Transplantation Autologous Cardiac Stem Cells Ischemic Heart Failure</brief_title>
	<detailed_description>Heart failure common , costly , disabling , potentially deadly condition . Heart transplantation ultimate approach treat heart failure , costly excludes patient poor candidate transplantation give co morbidity , donor organ unavailable . Currently , effective intervention regenerate dead heart muscle heart attack . Our hypothesis CSCs regenerate myocardium . In study eligible patient randomly allocate two study group permute block randomization method : group A ( case group ) receive 5-10 million autologous cardiac stem cell , group B ( control group ) receive placebo . They follow 18 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 EF≤40 ( Echocardiography ) 2 Not respond standard therapy heart failure &gt; 1m 3 NYHA class ≥ III 4 Myocardial infarction due coronary artery atherosclerotic disease 5An area regional dysfunction , i.e. , hypokinetic , akinetic , dyskinetic ( echocardiography MRI ) 6No HIV/Viral hepatitis 7Normal liver function ( SGPT &lt; 3 time upper reference range ) 8No control diabetes ( hemoglobin A1C &lt; 8.5 % ) 9 Ability provide inform consent followup protocol procedures 1 prior ICD placement ( &lt; 2w ) /Sustained ventricular arrhythmia 2Cardiogenic shock 3 pregnancy Childbearing 4 Congenital / valvular heart disease</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cardiac stem ce heart failure cardiac function intracoronary transplantation</keyword>
</DOC>